{"id":"https://openalex.org/W4296779201","doi":"https://doi.org/10.1089/met.2022.0052","title":"\u03b4-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial","display_name":"\u03b4-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial","publication_year":2022,"publication_date":"2022-09-20","ids":{"openalex":"https://openalex.org/W4296779201","doi":"https://doi.org/10.1089/met.2022.0052","pmid":"https://pubmed.ncbi.nlm.nih.gov/36125447"},"language":"en","primary_location":{"id":"doi:10.1089/met.2022.0052","doi":"https://doi.org/10.1089/met.2022.0052","is_oa":false,"landing_page_url":"https://doi.org/10.1089/met.2022.0052","pdf_url":null,"source":{"id":"https://openalex.org/S61453932","display_name":"Metabolic Syndrome and Related Disorders","issn_l":"1540-4196","issn":["1540-4196","1557-8518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic Syndrome and Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047101294","display_name":"Safia Fatima","orcid":"https://orcid.org/0000-0002-4550-9279","observed_orcids":["https://orcid.org/0000-0002-4550-9279"]},"institutions":[{"id":"https://openalex.org/I20755112","display_name":"Armed Forces Institute of Pathology","ror":"https://ror.org/03c24n351","country_code":"PK","type":"facility","lineage":["https://openalex.org/I20755112"]},{"id":"https://openalex.org/I4210155929","display_name":"National University of Medical Sciences","ror":"https://ror.org/04tj88f69","country_code":"PK","type":"education","lineage":["https://openalex.org/I4210155929"]}],"countries":["PK"],"is_corresponding":true,"raw_author_name":"Safia Fatima","raw_affiliation_strings":["Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan"],"raw_orcid":"https://orcid.org/0000-0002-4550-9279","affiliations":[{"raw_affiliation_string":"Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I20755112","https://openalex.org/I4210155929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031398109","display_name":"Dilshad Ahmad Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20755112","display_name":"Armed Forces Institute of Pathology","ror":"https://ror.org/03c24n351","country_code":"PK","type":"facility","lineage":["https://openalex.org/I20755112"]},{"id":"https://openalex.org/I4210155929","display_name":"National University of Medical Sciences","ror":"https://ror.org/04tj88f69","country_code":"PK","type":"education","lineage":["https://openalex.org/I4210155929"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Dilshad Ahmad Khan","raw_affiliation_strings":["Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I20755112","https://openalex.org/I4210155929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080602119","display_name":"Muhammad Aamir","orcid":"https://orcid.org/0000-0003-0580-3921","observed_orcids":["https://orcid.org/0000-0003-0580-3921"]},"institutions":[{"id":"https://openalex.org/I20755112","display_name":"Armed Forces Institute of Pathology","ror":"https://ror.org/03c24n351","country_code":"PK","type":"facility","lineage":["https://openalex.org/I20755112"]},{"id":"https://openalex.org/I4210155929","display_name":"National University of Medical Sciences","ror":"https://ror.org/04tj88f69","country_code":"PK","type":"education","lineage":["https://openalex.org/I4210155929"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Muhammad Aamir","raw_affiliation_strings":["Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I20755112","https://openalex.org/I4210155929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023196983","display_name":"Muhammad Amjad Pervez","orcid":"https://orcid.org/0000-0001-8562-4733","observed_orcids":["https://orcid.org/0000-0001-8562-4733"]},"institutions":[{"id":"https://openalex.org/I20755112","display_name":"Armed Forces Institute of Pathology","ror":"https://ror.org/03c24n351","country_code":"PK","type":"facility","lineage":["https://openalex.org/I20755112"]},{"id":"https://openalex.org/I4210155929","display_name":"National University of Medical Sciences","ror":"https://ror.org/04tj88f69","country_code":"PK","type":"education","lineage":["https://openalex.org/I4210155929"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Muhammad Amjad Pervez","raw_affiliation_strings":["Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I20755112","https://openalex.org/I4210155929"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014447093","display_name":"Fozia Fatima","orcid":"https://orcid.org/0000-0001-8237-5313","observed_orcids":["https://orcid.org/0000-0001-8237-5313"]},"institutions":[{"id":"https://openalex.org/I4210155929","display_name":"National University of Medical Sciences","ror":"https://ror.org/04tj88f69","country_code":"PK","type":"education","lineage":["https://openalex.org/I4210155929"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Fozia Fatima","raw_affiliation_strings":["Department of Health Professions Education, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Professions Education, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I4210155929"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047101294"],"corresponding_institution_ids":["https://openalex.org/I20755112","https://openalex.org/I4210155929"],"apc_list":null,"apc_paid":null,"fwci":2.6154,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.8996059,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"21","issue":"1","first_page":"25","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.2842000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.2842000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.16429999470710754,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10445","display_name":"Antioxidant Activity and Oxidative Stress","score":0.09870000183582306,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delta-tocotrienol","display_name":"delta-tocotrienol","score":0.9900000095367432},{"id":"https://openalex.org/keywords/resveratrol","display_name":"resveratrol","score":1.0},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cardiometabolic-risk-factors","display_name":"cardiometabolic risk factors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.656000018119812},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9750000238418579},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.6399999856948853},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7929999828338623},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/malondialdehyde","display_name":"malondialdehyde","score":0.9959999918937683},{"id":"https://openalex.org/keywords/total-antioxidant-capacity","display_name":"total antioxidant capacity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dietary-supplementation","display_name":"dietary supplementation","score":0.6470000147819519},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8159999847412109},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5070000290870667},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8019999861717224},{"id":"https://openalex.org/keywords/abdominal-obesity","display_name":"abdominal obesity","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9280513525009155},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.7748307585716248},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.7053771018981934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6646157503128052},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5186566710472107},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5137854218482971},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.45750972628593445},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4421791732311249},{"id":"https://openalex.org/C2778402494","wikidata":"https://www.wikidata.org/wiki/Q599756","display_name":"National Cholesterol Education Program","level":4,"score":0.4310319125652313},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3932543992996216},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.3754032254219055},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2769402265548706},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07619419693946838},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077185","descriptor_name":"Resveratrol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000083202","descriptor_name":"Cardiometabolic Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014810","descriptor_name":"Vitamin E","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019587","descriptor_name":"Dietary Supplements","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/met.2022.0052","doi":"https://doi.org/10.1089/met.2022.0052","is_oa":false,"landing_page_url":"https://doi.org/10.1089/met.2022.0052","pdf_url":null,"source":{"id":"https://openalex.org/S61453932","display_name":"Metabolic Syndrome and Related Disorders","issn_l":"1540-4196","issn":["1540-4196","1557-8518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic Syndrome and Related Disorders","raw_type":"journal-article"},{"id":"pmid:36125447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36125447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic syndrome and related disorders","raw_type":"Randomized Controlled Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1968388603","https://openalex.org/W1968563535","https://openalex.org/W1999364485","https://openalex.org/W2113097947","https://openalex.org/W2130717716","https://openalex.org/W2401467434","https://openalex.org/W2541108990","https://openalex.org/W2590042038","https://openalex.org/W2593054240","https://openalex.org/W2753508208","https://openalex.org/W2791822337","https://openalex.org/W2883633449","https://openalex.org/W2919001325","https://openalex.org/W2943960940","https://openalex.org/W2970777296","https://openalex.org/W3000403504","https://openalex.org/W3009768350","https://openalex.org/W3028752706","https://openalex.org/W3093165001","https://openalex.org/W3123841197","https://openalex.org/W3153681733","https://openalex.org/W3157975861","https://openalex.org/W3184737426","https://openalex.org/W3194634792","https://openalex.org/W4210337608","https://openalex.org/W4221002432","https://openalex.org/W4288045121"],"related_works":["https://openalex.org/W4387081648","https://openalex.org/W3035263785","https://openalex.org/W4366483596","https://openalex.org/W2898133187","https://openalex.org/W3092671565","https://openalex.org/W2607611543","https://openalex.org/W7203994041","https://openalex.org/W2970777296","https://openalex.org/W3035729075","https://openalex.org/W6906547463"],"abstract_inverted_index":{"Background:":[0],"Metabolic":[1],"syndrome":[2],"(MetS)":[3],"is":[4,15],"a":[5,16,28,121,132,163],"cluster":[6],"of":[7,24,47,74,77,84,175,253],"central":[8],"obesity,":[9],"hypertension,":[10],"hyperglycemia,":[11],"and":[12,38,49,58,101,109,131,152,191,235,251,255],"dyslipidemia.":[13],"It":[14],"global":[17],"health":[18],"issue":[19],"with":[20,35,62,87,201,266],"an":[21],"increased":[22],"risk":[23,56,249],"cardiovascular":[25],"disease.":[26],"Recently,":[27],"few":[29],"natural":[30],"products":[31],"have":[32],"been":[33],"reported":[34],"promising":[36],"anti-inflammatory":[37],"antioxidative":[39],"effects.":[40],"We":[41],"aimed":[42],"to":[43,182,189,214,219,227,233,242],"evaluate":[44],"the":[45,72,116,160,264],"impact":[46],"\u03b4-tocotrienol":[48],"resveratrol":[50,128],"mixture":[51],"(TRM)":[52],"supplementation":[53,204],"on":[54,95,147],"cardiometabolic":[55,248],"factors":[57,250],"biomarkers":[59,154,252],"in":[60,115,166,193,263,276],"patients":[61,86,265],"MetS.":[63,267],"Methods:":[64],"A":[65,82],"randomized":[66],"controlled":[67],"trial":[68,273],"was":[69,274],"conducted":[70],"at":[71],"hospitals":[73],"National":[75],"University":[76],"Medical":[78],"Sciences":[79],"Rawalpindi,":[80],"Pakistan.":[81],"total":[83,236],"82":[85],"MetS":[88],"aged":[89],"18\u201360":[90],"years":[91],"were":[92,119,145,197],"enrolled":[93],"based":[94],"International":[96],"Diabetes":[97],"Federation-2005":[98],"diagnostic":[99],"criteria":[100],"randomly":[102],"grouped":[103],"into":[104],"TRM":[105,117,161,203,245],"(n":[106,111],"=":[107,112],"41)":[108],"placebo":[110,133],"41).":[113],"Patients":[114],"group":[118],"given":[120],"400":[122,135],"mg":[123],"capsule":[124],"(\u03b4-tocotrienol":[125],"250":[126],"mg;":[127],"150":[129],"mg),":[130],"(cellulose":[134],"mg)":[136],"twice":[137],"daily":[138],"for":[139],"24":[140],"weeks.":[141],"The":[142,271],"biochemical":[143],"tests":[144],"analyzed":[146],"ADVIA":[148],"1800":[149],"Chemistry\u00ae":[150],"analyzer":[151],"inflammatory":[153],"by":[155],"ELISA":[156],"methods.":[157],"Results:":[158],"In":[159],"group,":[162],"significant":[164,260],"reduction":[165],"waist":[167],"circumference,":[168],"blood":[169],"pressure,":[170],"mean":[171],"(95%":[172],"confidence":[173],"interval)":[174],"fasting":[176],"plasma":[177],"glucose":[178],"\u22120.15":[179],"mmol/L":[180,187],"(\u22120.22":[181],"\u22120.08),":[183],"serum":[184],"triglyceride":[185],"\u22120.32":[186],"(\u22120.47":[188],"\u22120.17),":[190],"increment":[192],"high-density":[194],"lipoprotein":[195],"cholesterol":[196],"observed":[198],"as":[199],"compared":[200],"placebo.":[202],"also":[205],"improved":[206,247],"biomarkers:":[207],"high-sensitive":[208],"C-reactive":[209],"protein":[210],"\u22120.61":[211],"mg/L":[212],"(\u22120.89":[213],"\u22120.33),":[215],"interleukin-6-1.99":[216],"pg/mL":[217,225],"(\u22122.50":[218],"\u22121.48),":[220],"tumor":[221],"necrosis":[222],"factor-\u03b1":[223],"\u22122.19":[224],"(\u22122.55":[226],"\u22121.83),":[228],"malondialdehyde":[229],"\u22120.48":[230],"\u03bcmol/L":[231],"(\u22120.65":[232],"\u22120.30),":[234],"antioxidant":[237],"capacity":[238],"1.71":[239],"U/mL":[240],"(1.29":[241],"2.13).":[243],"Conclusion:":[244],"supplementations":[246],"inflammation":[254],"oxidative":[256],"stress":[257],"without":[258],"any":[259],"side":[261],"effects":[262],"Clinical":[268,279],"Trials":[269,280],"Registry:":[270],"clinical":[272],"registered":[275],"Sri":[277],"Lanka":[278],"Registry":[281],"(https://slctr.lk/trials/slctr-2019-021)":[282]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2022-09-23T00:00:00"}